AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|
22.1 C
New York
Wednesday, November 4, 2026

Tag: year

newsFORsourcecompanycontentinformationreleases1market

All-new Dodge Muscle, Dodge Thrill and Drift Rides, Ram NASCAR Concept and Celebrity Appearances Bring Fun for Performance Fans at 10th MotorTrend Presents Roadkill...

AUBURN HILLS, Mich., July 30, 2025 /PRNewswire/ -- ...

Banque Fédérative du Crédit Mutuel – 2025 half-year results press release

First half of 2025:
very strong business activity and solid results,
penalized by the non-recurring income tax surcharge

Highly Anticipated Amflow PL Carbon and PL Carbon Pro Hit the US Market

Amflow officially available for sale in the United States LOS ANGELES, July 30, 2025 /PRNewswire/ -- Amflow, the first brand equipped with the Avinox eDrive System,...

KLÉPIERRE: FIRST-HALF 2025 RESULTS: CONTINUED UNABATED GROWTH

PRESS RELEASE

Ohio Cannabis Retailer The Botanist Opens Solon’s First Dispensary

SOLON, Ohio, July 30, 2025 /PRNewswire/ -- The Botanist, Ohio's premier cannabis brand, today announced the opening of its sixth in-state dispensary at 33113...

Final results

FORESIGHT VENTURES VCT PLC
LEI: 213800R88MRC4Y3OIW86
29 July 2025

PuroClean Sets Sights on Massachusetts for Strategic Franchise Expansion

Fifteen Territories Available Across Boston, the Coast, and Key Metro Areas; In-Market PROPEL Event Scheduled for July 30-31 TAMARAC, Fla., July 30, 2025 /PRNewswire/ --...

Peach State Health Plan Builds Upon Community Partnership with Barrow County Schools to Support Student Health and Readiness

ATLANTA, July 30, 2025 /PRNewswire/ -- Peach State Health Plan ("PSHP"), a leading managed care organization in Georgia and a company of Centene Corporation...

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

Espervita’s EVT0185 Shows Dramatic Tumor Reduction and Immune Activation in Preclinical MASH-Driven Hepatocellular Carcinoma

ANN ARBOR, Mich., July 30, 2025 /PRNewswire/ -- Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking...

EuMentis Therapeutics Receives U.S. FDA Clearance of IND Application for EM-221, a Novel PDE10A Inhibitor for Schizophrenia

-Company expects to initiate Phase 2 study in 2H 2025- SAN DIEGO, July 30, 2025 /PRNewswire/ -- EuMentis Therapeutics, Inc., ("EuMentis"), a clinical-stage drug development company...

LearnLux Celebrates Five Years of Financial Wellbeing Partnership with Messer Construction Co.

BOSTON, July 30, 2025 /PRNewswire/ -- LearnLux, the leading workplace financial wellbeing provider, is proud to celebrate the fifth anniversary and continued success of...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsYear

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers